Ibuprofen/Paracetamol Alkaloid-Int (Ibuprofen, Paracetamol)

Ibuprofen inhibits cyclooxygenase‑1 and‑2 enzymes, lowering peripheral prostaglandin production and providing anti‑inflammatory, analgesic, and antipyretic effects. Paracetamol acts mainly in the central nervous system to inhibit COX activity and modulate the endocannabinoid system, adding further pain relief and fever reduction without strong peripheral anti‑inflammatory action.

The appropriate dose and dosing interval are determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and other medications. Patients should follow the prescriber’s instructions and the product label guidance.

Safety in pregnancy and lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the use of Ibuprofen/Paracetamol with their healthcare provider to weigh potential benefits against possible risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

The combination provides additive analgesic and antipyretic effects because ibuprofen and paracetamol act via different mechanisms. This can result in better pain control and fever reduction at lower individual doses compared with ibuprofen alone, potentially reducing the risk of dose‑related side effects.

Ibuprofen/Paracetamol Alkaloid-Int should be stored at ambient temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

The product is taken orally with a glass of water. It can be taken with or without food, but taking it with food may reduce the likelihood of gastrointestinal discomfort. Swallow tablets whole; do not crush or chew unless instructed otherwise.

Serious risks include gastrointestinal bleeding, severe liver injury, and acute kidney impairment. Patients should seek immediate medical attention if they notice black stools, yellowing of the skin or eyes, reduced urine output, or unexplained swelling.

Individuals with known hypersensitivity to ibuprofen, other NSAIDs, or paracetamol should avoid this product. It is also contraindicated in patients with severe renal or hepatic impairment, active peptic ulcer disease, and those taking anticoagulants without medical supervision.